Last updated: August 17, 2026

 FDA-Approved Stem Cells Treatments 

According to the FDA, there are currently only a limited number of stem cell therapies approved by the agency—including ones involving bone marrow, for bone marrow transplants in cancer care, and cord blood for specific blood-related disorders.
FDA-Approved Treatments
LEUKEMIAS
MYELODYSPLASTIC SYNDROMES
LYMPHOMAS
OTHER DISORDERS OF BLOOD CELL PROLIFERATION
INHERITED RED CELL ABNORMALITIES
INHERITED PLATELET ABNORMALITIES
INHERITED IMMUNE SYSTEM DISORDERS
NEUTROPENIAS
OTHER

LYMPHOPROLIFERATIVE DISORDERS
MYELOPROLIFERATIVE DISORDERS
PHAGOCYTE DISORDERS
TRANSPLANTS FOR INHERITED METABOLIC DISORDERS
LEUKODYSTROPHY DISORDERS
LYSOSOMAL STORAGE DISEASES
INHERITED DISORDERS: OTHER
SOLID TUMORS NOT ORIGINATING IN THE BLOOD OR IMMUNE SYSTEM

Scientific Case Review

Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?

Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.

• Review of the information you provide
• Relevant research and clinical program information
• A clear response focused on your situation

What happens next? Send your question, receive a focused scientific review, and get a clear response about research and clinical programs relevant to your situation.

Your scientific review will be prepared by Dr. Helen Melnik, PhD , who has more than 25 years of experience in stem cell research and international clinical programs.

☎ WhatsApp Request My Personal Scientific Review ✉ Email Request My Personal Scientific Review

No obligation. Your question will be reviewed confidentially.

Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.